Extracorporeal Hemoperfusion as a Potential Therapeutic Option for Severe COVID-19 patients; a Narrative Review.
Adult
COVID-19
Respiratory Distress Syndrome
cytokine release syndrome
hemoperfusion
Journal
Archives of academic emergency medicine
ISSN: 2645-4904
Titre abrégé: Arch Acad Emerg Med
Pays: Iran
ID NLM: 101740147
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
2
11
2020
pubmed:
3
11
2020
medline:
3
11
2020
Statut:
epublish
Résumé
The 2019 novel coronavirus (officially known as severe acute respiratory syndrome coronavirus 2, SARS-CoV2) was first found in Wuhan, China. On February 11, 2020, the World Health Organization (WHO) has declared the outbreak of the disease caused by SARS-CoV2, named coronavirus disease 2019 (COVID-19), as an emergency of international concern. Based on the current epidemiological surveys, some COVID-19 patients with severe infection gradually develop impairment of the respiratory system, acute kidney injury (AKI), multiple organ failure, and ultimately, death. Currently, there is no established pharmacotherapy available for COVID-19. As seen in influenza, immune damage mediated by excessive production of inflammatory mediators contributes to high incidence of complications and poor prognosis. Thus, removal or blocking the overproduction of these mediators potentially aids in reducing the deleterious cytokine storm and improving critically ill patients' outcomes. Based on previous experience of blood purification to treat cytokine storm syndrome (CSS) in severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), here we aimed to review the current literature on extracorporeal hemoperfusion as a potential therapeutic option for CSS-associated conditions, with a focus on severe COVID-19.
Types de publication
Journal Article
Review
Langues
eng
Pagination
e67Références
Artif Organs. 2019 Feb;43(2):189-194
pubmed: 30156308
Indian J Crit Care Med. 2014 Dec;18(12):822-4
pubmed: 25538418
Intensive Care Med. 2010 May;36(5):906-7
pubmed: 20224904
Nat Med. 2013 Oct;19(10):1313-7
pubmed: 24013700
Crit Care. 2017 Mar 27;21(1):74
pubmed: 28343448
Ther Apher Dial. 2013 Aug;17(4):454-61
pubmed: 23931889
J Lab Clin Med. 1948 Jul;33(7):841-4
pubmed: 18869571
Int J Artif Organs. 2015 Aug;38(8):461-4
pubmed: 26349530
Hong Kong Med J. 2005 Jun;11(3):189-99
pubmed: 15951584
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
In Vivo. 2020 Nov-Dec;34(6):3723-3730
pubmed: 33144490
J Pharmacol Exp Ther. 1960 Mar;128:318-27
pubmed: 14429956
Med Klin Intensivmed Notfmed. 2019 Nov;114(8):699-707
pubmed: 28871441
Case Rep Crit Care. 2019 Jul 30;2019:5740503
pubmed: 31467732
Blood Purif. 2019;47(1-3):94-100
pubmed: 30253409
J Med Virol. 2005 Feb;75(2):185-94
pubmed: 15602737
J Crit Care. 2020 Jun;57:124-129
pubmed: 32113143
Intensive Care Med. 2019 Feb;45(2):236-239
pubmed: 30446798
PLoS Med. 2006 Sep;3(9):e343
pubmed: 16968120
J Virol. 2010 Feb;84(3):1414-22
pubmed: 19939920
Lancet Respir Med. 2020 Mar;8(3):240-241
pubmed: 32035509
Ther Apher Dial. 2010 Dec;14(6):596-602
pubmed: 21118369
J Am Med Assoc. 1951 May 12;146(2):105-6
pubmed: 14823905
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Blood Purif. 2018;46(4):337-349
pubmed: 30176653
BMC Infect Dis. 2020 Dec 21;20(1):963
pubmed: 33349241
Ann Intensive Care. 2018 Dec 7;8(1):121
pubmed: 30535929
Nihon Rinsho. 2003 Nov;61(11):1953-8
pubmed: 14619437
Crit Rev Oncol Hematol. 2002 Dec;44(3):259-72
pubmed: 12467966
Int J Artif Organs. 2006 Feb;29(2):239-50
pubmed: 16552671
J Clin Invest. 2020 May 1;130(5):2202-2205
pubmed: 32217834
JAMA. 2018 Oct 9;320(14):1455-1463
pubmed: 30304428
Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15196-200
pubmed: 15477589
AMA Arch Intern Med. 1958 Dec;102(6):896-913
pubmed: 13593896
Respirol Case Rep. 2015 Jun;3(2):57-60
pubmed: 26090112
Lancet Infect Dis. 2003 Apr;3(4):191-200
pubmed: 12679262
J Immunother. 2018 Nov/Dec;41(9):406-410
pubmed: 30198955
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Int J Artif Organs. 2006 Feb;29(2):251-60
pubmed: 16552672
Crit Care. 2017 Jun 7;21(1):134
pubmed: 28592318
J Cancer Res Clin Oncol. 2020 Apr;146(4):1065-1077
pubmed: 32076823
Contrib Nephrol. 2010;167:25-34
pubmed: 20519896
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Immunol Lett. 2020 Aug;224:12-13
pubmed: 32473971
Bone Marrow Transplant. 2000 Sep;26(6):591-7
pubmed: 11035367
Intensive Care Med. 2018 Dec;44(12):2205-2212
pubmed: 30470853
Proc R Soc Med. 1970 May;63(5):427-30
pubmed: 4916564
J Gen Virol. 2013 Dec;94(Pt 12):2679-2690
pubmed: 24077366
Lancet Infect Dis. 2014 Nov;14(11):1090-1095
pubmed: 25278221
Crit Care. 2018 Oct 25;22(1):262
pubmed: 30360755